BIOMAT Database Logo BIOMAT Database Logo

The effect of cirrhosis on the disposition and elimination of clindamycin. 1975

G R Avant, and S Schenker, and R H Alford

This study assessed the effect of alcoholic cirrhosis in man and of experimental liver injury in rats on the disposition and elimination of clindamycin. In 7 cirrhotics a statistically significant, although modest, prolongation of clindamycin half-life (T1/2beta) was observed as compared to values in 7 age-matched normal contrals (mean plus or minus SD: 4.46 plus or minus 0.93 hr vs 3.42 plus or minus 0.45 hr, P equals 0.02). This was primarily due to a decrease in clindamycin serum clearance in the cirrhotics, since the volume of distribution of the drug was similar in both groups (P more than 0.05). Serum protein binding of clindamycin was of the order of 79% and was comparable in both groups (P more than 0.05). There was a significant correlation between the T1/2beta of the drug and both total serum bilirubin and SGOT. The T1/2beta of clindamycin was also prolonged in rats with acute hepatic necrosis induced by administration of carbon tetrachloride and those with acute cholestasis caused by common bile duct ligation. These data suggest that liver damage, both chronic and acute, impairs the elimination of clindamycin but that this effect is small.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002252 Carbon Tetrachloride Poisoning Poisoning that results from ingestion, injection, inhalation, or skin absorption of CARBON TETRACHLORIDE. CCl4 Poisoning,Poisoning, CCl4,Poisoning, Carbon Tetrachloride,CCl4 Poisonings,Carbon Tetrachloride Poisonings,Poisonings, Carbon Tetrachloride
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin

Related Publications

G R Avant, and S Schenker, and R H Alford
The effect of cirrhosis on the disposition and elimination of meperidine in man.
October 1974, Clinical pharmacology and therapeutics,
G R Avant, and S Schenker, and R H Alford
Flumazenil disposition and elimination in cirrhosis.
September 1989, Clinical pharmacology and therapeutics,
G R Avant, and S Schenker, and R H Alford
Fluoxetine disposition and elimination in cirrhosis.
September 1988, Clinical pharmacology and therapeutics,
G R Avant, and S Schenker, and R H Alford
The effect of fenfluramine on disposition and rate of antipyrine elimination.
January 1975, Pharmacology,
G R Avant, and S Schenker, and R H Alford
The effect of ethanol administration on the disposition and elimination of chlormethiazole.
January 1983, European journal of clinical pharmacology,
G R Avant, and S Schenker, and R H Alford
Effect of cirrhosis and debrisoquin phenotype on the disposition and effects of pinacidil.
December 1986, Clinical pharmacology and therapeutics,
G R Avant, and S Schenker, and R H Alford
The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
July 1975, The Medical clinics of North America,
G R Avant, and S Schenker, and R H Alford
Effect of acute viral hepatitis in man on the disposition and elimination of meperidine.
April 1975, Gastroenterology,
G R Avant, and S Schenker, and R H Alford
Disposition of intravenous glycofurol: effect of hepatic cirrhosis.
July 1984, Clinical pharmacology and therapeutics,
G R Avant, and S Schenker, and R H Alford
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).
September 1978, Gastroenterology,
Copied contents to your clipboard!